Concepedia

397O Avelumab plus cetuximab in pre-treated RAS wild type metastatic colorectal cancer patients as a rechallenge strategy: The phase II CAVE (cetuximab-avelumab) mCRC study

Erika Martinelli, Giulia Martini, Teresa Troiani, Filippo Pietrantonio, Antonio Avallone, Nicola Normanno, Anna Nappi, Evaristo Maiello, Alfredo Falcone, Giuseppe Santabarbara,

Annals of Oncology · 2020 · 23 citations · 0 references

Concepts

MedicineOncologyPharmacologyCancer PharmacologyGastrointestinal OncologyMetastasisCancer ImmunotherapyColorectal CancerGastrointestinal Cancer PharmacotherapyMalignant NeoplasmsMetastatic Cancer ManagementMetastatic Gastrointestinal CancerCetuximab TherapyDose RechallengeRechallenge Dosing